Get the latest news on Shield Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SHIEF performance

Latest Shield Therapeutics Stock News | OTC:SHIEF | Benzinga

Shield Therapeutics PLC is a commercial stage specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals that address areas of high unmet medical need. The company's operating segments are based on key products including PT20 and Feraccru, involves development and commercialisation of the Group's main Feraccru product, and PT20 is used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from the Feraccru segment.

SHIELD THERAPEUTICS PLC by Shield Therapeutics PLC

Comments

Shield Therapeutics Stock News

News

Latest Shield Therapeutics Stock News | OTC:SHIEF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga